Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Huntington's disease | R-HSA-1643685 | 0 | digoxigenin | 4826 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | digoxigenin | 4826 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | digoxigenin | 4826 | drug-path |
Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | digoxigenin | 4826 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | digoxigenin | 4826 | drug-path |
Cardiac muscle contraction | R-HSA-397014 | map04260 | digoxigenin | 4826 | drug-path |
Vascular smooth muscle contraction | R-HSA-445355 | map04270 | digoxigenin | 4826 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | digoxigenin | 4826 | drug-path |
Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | digoxigenin | 4826 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | digoxigenin | 4826 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | digoxigenin | 4826 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | digoxigenin | 4826 | drug-path |
Pathways in cancer | R-HSA-9824443 | map05200 | digoxigenin | 4826 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | digoxigenin | 4826 | drug-path |
Leukocyte transendothelial migration | R-HSA-8950732 | map04670 | digoxigenin | 4826 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | digoxigenin | 4826 | drug-path |
Focal adhesion | R-HSA-354113 | map04510 | digoxigenin | 4826 | drug-path |
Tight junction | R-HSA-2134514 | map04530 | digoxigenin | 4826 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | digoxigenin | 4826 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | digoxigenin | 4826 | drug-path |